Invest and Sell Benchling Stock

Benchling stock price

Forge Price ¹

Price not yet available

Last Closed Trade ²

Close Date

xx/xx/xx

Last Closed Trade Price

$xx.xx

Last Funding Round (LFR)

Date

xx/xx/xx

Price per Share

$xx.xx

Access Stock Price

Benchling funding rounds and valuation

Funding history chart

Funding round details

	Funding Date	Share Class	Amount Raised	Price per Share	Post-Money Valuation	Key Investors
	11/18/2021	Series F	$95MM	$xx.xx	$6.1B	Altimeter Capital, Franklin Templeton, Lone Pine Capital, Tiger Global
Price per Share $xx.xx Shares Outstanding 2,905,528 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Altimeter Capital, Franklin Templeton, Lone Pine Capital, Tiger Global
	11/18/2021	Series F-1	$11MM	$xx.xx	$6.1B	Altimeter Capital, Franklin Templeton, Lone Pine Capital, Tiger Global
Price per Share $xx.xx Shares Outstanding 336,429 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Altimeter Capital, Franklin Templeton, Lone Pine Capital, Tiger Global
	04/14/2021	Series E	$200MM	$xx.xx	$4B	Alkeon Capital, Altimeter Capital, Benchmark, Byers Capital, Elad Gil, Iconiq, Lead Edge Capital, Lux Capital, Menlo Ventures, Sequoia Capital, Spark Capital, Thrive Capital
Price per Share $xx.xx Shares Outstanding 8,614,020 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Alkeon Capital, Altimeter Capital, Benchmark, Byers Capital, Elad Gil, Iconiq, Lead Edge Capital, Lux Capital, Menlo Ventures, Sequoia Capital, Spark Capital, Thrive Capital
	05/28/2020	Series D	$50.55MM	$xx.xx	$850MM	Alkeon, Benchmark, Iconiq Partners, Lux Capital, Menlo Ventures, Spark Capital, Thrive Capital
Price per Share $xx.xx Shares Outstanding 9,099,735 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Alkeon, Benchmark, Iconiq Partners, Lux Capital, Menlo Ventures, Spark Capital, Thrive Capital
	07/24/2019	Series C	$37.03MM	$xx.xx	$409.65MM	Benchmark, Lead Edge Capital, Menlo Ventures, Thrive Capital, Y Combinator
Price per Share $xx.xx Shares Outstanding 12,973,581 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Benchmark, Lead Edge Capital, Menlo Ventures, Thrive Capital, Y Combinator
	06/14/2018	Series B	$18.25MM	$xx.xx	$85.05MM	Benchmark, F-Prime Capital, Thrive Capital
Price per Share $xx.xx Shares Outstanding 28,306,704 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Benchmark, F-Prime Capital, Thrive Capital
	10/24/2016	Series A	$7MM	$xx.xx	$37.94MM	Andreessen Horowitz, �Ashton Kutcher, David Wallerstein, �Geoff Ralston, �Matt Huang, Thrive Capital
Price per Share $xx.xx Shares Outstanding 15,445,755 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Andreessen Horowitz, �Ashton Kutcher, David Wallerstein, �Geoff Ralston, �Matt Huang, Thrive Capital
	04/15/2015	Series Seed	$6.14MM	$xx.xx	$17.54MM	Andreessen Horowitz, Ff Angel, Geoff Ralston, Kevin Mahaffey, Matt Huang, Rock Health, Sv Angel, Thrive Capital, Tim Draper, Y Combinator
Price per Share $xx.xx Shares Outstanding 22,212,279 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Andreessen Horowitz, Ff Angel, Geoff Ralston, Kevin Mahaffey, Matt Huang, Rock Health, Sv Angel, Thrive Capital, Tim Draper, Y Combinator

Access Stock Price

Company details

Benchling, founded in 2012, is the developer of a biotech platform for biology researchers and research organizations. The cloud-based R&D platform is designed to be an “all-in-one experiment, sample, process, and lab management system”, aiming to make research more accessible, while enabling researchers and scientists to be more collaborative.

benchling.com

Sector

Healthcare

Subsector

Healthcare Software

Founded

2012

Headquarters

San Francisco, CA, United States

Post-Money Valuation ³

$6.1B

Total Funding

$424.97MM

LFR Price per Share

$xx.xx

Last Funding Share Class

Series F

Benchling stock FAQs

To buy and sell Benchling stock

Can you buy Benchling stock?

As Benchling is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private companies like Benchling, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.

How to buy Benchling stock?

To invest in a private company like Benchling through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Benchling stock?

Yes, you may sell the Benchling stock you currently own. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company’s interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Benchling stock?

If you hold private company shares of Benchling – whether as an employee or an early investor – Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Benchling on our platform.
Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

To learn more about Benchling stock

Is Benchling a public company?

No, Benchling is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Benchling’s stock price?

Benchling is a privately held company and therefore does not have a public stock price. However, you may access Benchling private market stock price with Forge Data.

What is Benchling’s stock ticker symbol?

Benchling does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Leadership and board

Leadership

Sajith Wickramasekara

Co-Founder & Chief Executive Officer

Ashutosh Singhal

Co-Founder & President

Richard Wong

Chief Financial Officer

Stephen Deasy

Chief Technology Officer

Zach Powers

Chief Information Security Officer

Lindsey Irvine

Chief Marketing Officer

Niall Wall

Chief Partner Officer & Head of Partners

Shawna Wolverton

Chief Product Officer

Board

Miles Grimshaw

Thrive Capital

Eric Vishria

Benchmark

William Griffith

ICONIQ Growth

Other companies like Benchling in the Healthcare Software sector

Sector: Healthcare

Subsector: Healthcare Software

					Last Funding Round
Company		Forge Price	Forge Price Change ⁵	Last Closed Trade	Share Class	Post-Money Valuation	Price per Share	Amount Raised
	Abridge	--	--	$xx.xx	Series E	$5.3B	$xx.xx	$300MM
	Cohere Health	--	--	$xx.xx	Series C	$724.92MM	$xx.xx	$90MM
	DeepScribe	--	--	$xx.xx	Series B	$134.68MM	$xx.xx	$24MM
	Innovaccer	$3.29	-6.00%	$xx.xx	Series F-1	$3.45B	$xx.xx	$153.04MM
	Insilico Medicine	--	--	$xx.xx	--	--	--	--
	OpenEvidence	--	--	$xx.xx	Series B-1	$3.47B	$xx.xx	$30MM
	Parsley Health	--	--	$xx.xx	Series 1	$20.94MM	$xx.xx	$15MM
	Pathos	--	--	$xx.xx	Series D	$1.6B	$xx.xx	$331.82MM
	Prompt	--	--	$xx.xx	Series B	$929.95MM	$xx.xx	$206MM
	Viz.ai	--	--	$xx.xx	Series D	$1.28B	$xx.xx	$120MM

See All Companies

Forge is your trusted partner to buy and sell Benchling stock

Forge is the trusted platform for buying and selling private company stock. Investors and shareholders worldwide rely on our deep data insights, liquidity solutions, and tailored investment opportunities to navigate the private market. Register to get started.

First time buying private market stock?

New to selling your private company stock?

Updated on: Jul 9, 2025

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.
Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

The news articles displayed on this page may be curated using artificial intelligence (AI) technology, which selects relevant content from a list of trusted web sources. While we strive for accuracy and reliability, the inclusion of an article does not imply endorsement or verification of its content. This communication is for informational purposes only. Investors should conduct their own research and consult a financial professional before making investment decisions.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.

Benchling stock